Yanai A - Search Results

1

Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.

Hirata Y, Ohmae T, Yanai A, Sakitani K, Hayakawa Y, Yoshida S, Sugimoto T, Mitsuno Y, Akanuma M, Yamaji Y, Ogura K, Maeda S, Koike K. Hirata Y, et al. Among authors: yanai a. Int J Antimicrob Agents. 2012 Apr;39(4):352-5. doi: 10.1016/j.ijantimicag.2011.12.002. Epub 2012 Feb 7. Int J Antimicrob Agents. 2012. PMID: 22321702 Clinical Trial.

2

Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori.

Ogura K, Mitsuno Y, Maeda S, Hirata Y, Yanai A, Shibata W, Ohmae T, Yoshida H, Kawabe T, Omata M. Ogura K, et al. Among authors: yanai a. Helicobacter. 2007 Dec;12(6):618-22. doi: 10.1111/j.1523-5378.2007.00551.x. Helicobacter. 2007. PMID: 18001403 Clinical Trial.

3

Clinical relevance of Helicobacter pylori sabA genotype in Japanese clinical isolates.

Yanai A, Maeda S, Hikiba Y, Shibata W, Ohmae T, Hirata Y, Ogura K, Yoshida H, Omata M. Yanai A, et al. J Gastroenterol Hepatol. 2007 Dec;22(12):2228-32. doi: 10.1111/j.1440-1746.2007.04831.x. J Gastroenterol Hepatol. 2007. PMID: 18031386

4

The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.

Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, Maeda S, Watabe H, Yamaji Y, Okamoto M, Yoshida H, Kawabe T, Omata M. Ogura K, et al. Among authors: yanai a. J Clin Gastroenterol. 2008 Mar;42(3):279-83. doi: 10.1097/01.mcg.0000248006.80699.7f. J Clin Gastroenterol. 2008. PMID: 18223496

5

Influence of Helicobacter pylori eradication on the management of type 2 diabetes.

Akanuma M, Yanai A, Sakamoto K, Hirata Y, Yamaji Y, Kawazu S, Maeda S. Akanuma M, et al. Among authors: yanai a. Hepatogastroenterology. 2012 Mar-Apr;59(114):641-5. doi: 10.5754/hge11960. Hepatogastroenterology. 2012. PMID: 22328266

6

Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients.

Sakitani K, Hirata Y, Suzuki N, Shichijo S, Yanai A, Serizawa T, Sakamoto K, Akanuma M, Maeda S, Yamaji Y, Iwamoto Y, Kawazu S, Koike K. Sakitani K, et al. Among authors: yanai a. BMC Gastroenterol. 2015 Oct 21;15:143. doi: 10.1186/s12876-015-0377-0. BMC Gastroenterol. 2015. PMID: 26486595 Free PMC article.

7

CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model.

Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A, Mitsuno Y, Yamaji Y, Okamoto M, Yoshida H, Kawabe T, Omata M. Shibata W, et al. Among authors: yanai a. J Pathol. 2006 Nov;210(3):306-14. doi: 10.1002/path.2040. J Pathol. 2006. PMID: 16933206

8

Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation.

Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M, Yoshida H, Kawabe T, Shiratori Y, Omata M. Hirata Y, et al. Among authors: yanai a. Gastroenterology. 2002 Dec;123(6):1962-71. doi: 10.1053/gast.2002.37044. Gastroenterology. 2002. PMID: 12454853

9

Helicobacter pylori induces antiapoptosis through buclear factor-kappaB activation.

Yanai A, Hirata Y, Mitsuno Y, Maeda S, Shibata W, Akanuma M, Yoshida H, Kawabe T, Omata M. Yanai A, et al. J Infect Dis. 2003 Dec 1;188(11):1741-51. doi: 10.1086/379629. Epub 2003 Nov 25. J Infect Dis. 2003. PMID: 14639546

10

Functional variability of cagA gene in Japanese isolates of Helicobacter pylori.

Hirata Y, Yanai A, Shibata W, Mitsuno Y, Maeda S, Ogura K, Yoshida H, Kawabe T, Omata M. Hirata Y, et al. Among authors: yanai a. Gene. 2004 Dec 8;343(1):165-72. doi: 10.1016/j.gene.2004.08.026. Gene. 2004. PMID: 15563842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters